MDM2

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

MDM2

Jun 2, 2024, 12:11 | Blog

New clinical data being presented at the ASCO from our ongoing KT-253 Phase 1 oncology trial - Kymera Therapeutics

Pearl Freier, Founder of Cambridge BioPartners, shared a post by Kymera Therapeutics on X/Twitter: "…

May 17, 2024, 04:29 | Insight

Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations

Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…

May 12, 2024, 06:02 | Insight

Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia

Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…

Mar 26, 2024, 00:22 | Opinion

Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants

Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…

All: 4 Posts: 1 - 100

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023